Vi­core sells rights to IPF drug in Japan; Roche to lay off 340 work­ers; Sen­so­ri­on’s €50M of­fer­ing

Plus, news about Tenaya Ther­a­peu­tics, Ad­verum Biotech­nolo­gies, YS Bio­phar­ma, Evoke Phar­ma and BioX­cel Ther­a­peu­tics:

Nip­pon Shinyaku gets rights in Japan to IPF drug: The Japan­ese …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA